| The probabilistic model of Alzheimer disease: the amyloid hypothesis revised GB Frisoni, D Altomare, DR Thal, F Ribaldi, R van der Kant, ... Nature Reviews Neuroscience 23 (1), 53-66, 2022 | 299 | 2022 |
| Dementia prevention in memory clinics: recommendations from the European task force for brain health services GB Frisoni, D Altomare, F Ribaldi, N Villain, C Brayne, N Mukadam, ... The Lancet Regional Health–Europe 26, 2023 | 58 | 2023 |
| Modifiable risk factors for dementia and dementia risk profiling. A user manual for Brain Health Services—part 2 of 6 JM Ranson, T Rittman, S Hayat, C Brayne, F Jessen, K Blennow, ... Alzheimer's Research & Therapy 13, 1-12, 2021 | 53 | 2021 |
| Comparison of bioinformatics pipelines and operating systems for the analyses of 16S rRNA gene amplicon sequences in human fecal samples M Marizzoni, T Gurry, S Provasi, G Greub, N Lopizzo, F Ribaldi, C Festari, ... Frontiers in microbiology 11, 1262, 2020 | 53 | 2020 |
| Brain Health Services: organization, structure, and challenges for implementation. A user manual for Brain Health Services—part 1 of 6 D Altomare, JL Molinuevo, C Ritchie, F Ribaldi, E Carrera, B Dubois, ... Alzheimer's research & therapy 13, 1-11, 2021 | 40 | 2021 |
| Multidomain interventions: state-of-the-art and future directions for protocols to implement precision dementia risk reduction. A user manual for Brain Health Services—part 4 of 6 A Solomon, R Stephen, D Altomare, E Carrera, GB Frisoni, J Kulmala, ... Alzheimer's research & therapy 13, 1-15, 2021 | 38 | 2021 |
| Accuracy and reproducibility of automated white matter hyperintensities segmentation with lesion segmentation tool: A European multi-site 3T study F Ribaldi, D Altomare, J Jovicich, C Ferrari, A Picco, FB Pizzini, A Soricelli, ... Magnetic resonance imaging 76, 108-115, 2021 | 30 | 2021 |
| The A/T/N model applied through imaging biomarkers in a memory clinic A Dodich, A Mendes, F Assal, C Chicherio, B Rakotomiaramanana, ... European journal of nuclear medicine and molecular imaging 47, 247-255, 2020 | 30 | 2020 |
| Diagnostic value of amyloid-PET and tau-PET: a head-to-head comparison D Altomare, C Caprioglio, F Assal, G Allali, A Mendes, F Ribaldi, ... European journal of nuclear medicine and molecular imaging 48, 2200-2211, 2021 | 29 | 2021 |
| Dementia risk communication. A user manual for Brain Health Services—part 3 of 6 LNC Visser, C Minguillon, G Sánchez-Benavides, M Abramowicz, ... Alzheimer's Research & Therapy 13, 1-12, 2021 | 23 | 2021 |
| Predicting and tracking short term disease progression in amnestic mild cognitive impairment patients with prodromal Alzheimer’s disease: structural brain biomarkers M Marizzoni, C Ferrari, J Jovicich, D Albani, C Babiloni, L Cavaliere, ... Journal of Alzheimer's Disease 69 (1), 3-14, 2019 | 22 | 2019 |
| Association of postoperative delirium with markers of neurodegeneration and brain amyloidosis: a pilot study E Rolandi, E Cavedo, M Pievani, S Galluzzi, F Ribaldi, C Buckley, ... Neurobiology of aging 61, 93-101, 2018 | 22 | 2018 |
| Protocols for cognitive enhancement. A user manual for Brain Health Services—part 5 of 6 A Brioschi Guevara, M Bieler, D Altomare, M Berthier, C Csajka, ... Alzheimer's Research & Therapy 13, 1-13, 2021 | 21* | 2021 |
| Brain connectivity and metacognition in persons with subjective cognitive decline (COSCODE): rationale and study design F Ribaldi, C Chicherio, D Altomare, M Martins, S Tomczyk, I Jelescu, ... Alzheimer's Research & Therapy 13 (1), 105, 2021 | 18 | 2021 |
| Societal and equity challenges for Brain Health Services. A user manual for Brain Health Services—part 6 of 6 R Milne, D Altomare, F Ribaldi, JL Molinuevo, GB Frisoni, C Brayne, ... Alzheimer's Research & Therapy 13, 1-8, 2021 | 15* | 2021 |
| CSF cutoffs for MCI due to AD depend on APOEε4 carrier status M Marizzoni, C Ferrari, C Babiloni, D Albani, F Barkhof, L Cavaliere, ... Neurobiology of aging 89, 55-62, 2020 | 15 | 2020 |
| Analysis of psychological symptoms following disclosure of amyloid–positron emission tomography imaging results to adults with subjective cognitive decline C Caprioglio, F Ribaldi, LNC Visser, C Minguillon, LE Collij, ... JAMA network open 6 (1), e2250921-e2250921, 2023 | 12 | 2023 |
| Early-phase 18F-Florbetapir and 18F-Flutemetamol images as proxies of brain metabolism in a memory clinic setting C Boccalini, DE Peretti, F Ribaldi, M Scheffler, S Stampacchia, S Tomczyk, ... Journal of Nuclear Medicine 64 (2), 266-273, 2023 | 11 | 2023 |
| The clinical heterogeneity of subjective cognitive decline: a data-driven approach on a population-based sample F Ribaldi, E Rolandi, R Vaccaro, M Colombo, G Battista Frisoni, A Guaita Age and Ageing 51 (10), afac209, 2022 | 10 | 2022 |
| Randomized controlled trial on the efficacy of a multilevel non-pharmacologic intervention in older adults with subjective memory decline: design and baseline findings of the E … E Rolandi, A Dodich, S Galluzzi, C Ferrari, S Mandelli, F Ribaldi, ... Aging clinical and experimental research 32, 817-826, 2020 | 9 | 2020 |
